Clin Mol Hepatol.
2022 Jul;28(3):478-480. 10.3350/cmh.2022.0143.
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
- Affiliations
-
- 1Department of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Korea
- 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- 3Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea
- KMID: 2531371
- DOI: http://doi.org/10.3350/cmh.2022.0143
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
- The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
- Clinical Predictors Reflecting the Pathologic Severity of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver
